- Butyrate Protects against Diet-Induced NASH and Liver Fibrosis and Suppresses Specific Non-Canonical TGF-β Signaling Pathways in Human Hepatic Stellate Cells
Eveline Gart et al, 2021, Biomedicines CrossRef - Inhibition of plasminogen suppresses fibrosis and macrophage foaming in a nonalcoholic steatohepatitis mouse model
Yuki Tomonari et al, 2022, Fundamental & Clinical Pharmacology CrossRef - Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1
Abd Aziz Ibrahim et al, 2024, Frontiers in Immunology CrossRef - Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets
Ralf-Peter Czekay et al, 2022, Cancers CrossRef - Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
Yajie Fu et al, 2022, Frontiers in Pharmacology CrossRef - Comparison of plasminogen activator inhibitor-1 levels in chronic hepatitis B patients with hepatic cirrhosis and without hepatic cirrhosis
Andhika Kusuma Hamdany et al, 2022, Open Access Macedonian Journal of Medical Sciences CrossRef - Association between Equol Production Status and Nonalcoholic Steatohepatitis
Takemi Akahane et al, 2021, International Journal of Molecular Sciences CrossRef